Cost ‐Effectiveness Analysis of Peripheral Nerve Field Stimulation as Add‐On Therapy to Spinal Cord Stimulation in the Treatment of Chronic Low Back Pain in Failed Back Surgery Syndrome Patients

ConclusionsFrom a Dutch national health ‐care context, when the willingness to pay threshold is up to 60.000 Euros per QALY, PNFS as an add‐on therapy to SCS for the treatment of low back pain in FBSS patients has a high probability of being cost‐effective.

Source: Neuromodulation: Technology at the Neural Interface - August 17, 2019 Category: Biotechnology Authors: Eric ‐Jan J.A.A van Gorp, Eddy M.M. Adang, Ismail Gültuna, Tanja E. Hamm‐Faber, Katja Bürger, Jan Willem Kallewaard, Johannes W.C.L Schapendonk, Leon Vonhögen, Ewald Bronkhorst, Onno P. Teernstra, Kris C.P. Vissers Tags: Clinical Research Source Type: research